Virological and Pharmacological Parameters Predicting the Response to Lopinavir-Ritonavir in Heavily Protease Inhibitor-Experienced Patients

The genotypic inhibitory quotient (GIQ) has been proposed as a way to integrate drug exposure and genotypic resistance to protease inhibitors and can be useful to enhance the predictivity of virologic response for boosted protease inhibitors. The aim of this study was to evaluate the predictivity of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Marcelin, Anne-Geneviève, Cohen-Codar, Isabelle, King, Martin S., Colson, Philippe, Guillevic, Emmanuel, Descamps, Diane, Lamotte, Claire, Schneider, Véronique, Ritter, Jacques, Segondy, Michel, Peigue-Lafeuille, Hélène, Morand-Joubert, Laurence, Schmuck, Anne, Ruffault, Annick, Palmer, Pierre, Chaix, Marie-Laure, Mackiewicz, Vincent, Brodard, Véronique, Izopet, Jacques, Cottalorda, Jacqueline, Kohli, Evelyne, Chauvin, Jean-Pierre, Kempf, Dale J., Peytavin, Gilles, Calvez, Vincent
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2005
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1087618/
https://ncbi.nlm.nih.gov/pubmed/15855487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.5.1720-1726.2005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak